ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?
Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Compared to Novo Nordisk's Ozempic, Zaynich’s billion potential counters global antibiotic resistance.
Announcement as on 06 July 2024

Why Novo Nordisk Topped the Market Today
Hardly for the first time in recent weeks and months, Novo Nordisk (NYSE: NVO) had a good trading session on the stock market Monday. The company's shares enjoyed a more than 2% boost on the day, comparing favorably to the 0.9% rise of the S&P 500 inde
Announcement as on 22 April 2024

Novo Nordisk to buy Cardior Pharma for up to billion
Novo Nordisk A/S bought Cardior Pharmaceuticals for billion to enhance cardiovascular treatments. Cardior's microRNA-targeting therapies aim to improve heart function, aligning with Novo's focus on diabetes and obesity history.
Announcement as on 26 March 2024

Novo Nordisk owner joins the race for Healthium Medtech
Novo Holdings is the latest challenger in a hotly contested bidding process for Healthium, 99.8% owned by Apax Partners. Buyout funds KKR, Hillhouse, EQT, Blackstone and TA Associates among others have already been shortlisted after the initial rounds, ET
Announcement as on 22 March 2024

Why Novo Nordisk Stock Was a Winner Today
One of the healthcare stocks of the moment, Novo Nordisk (NYSE: NVO), had a good Tuesday on the market. Investors pushed its price 3% higher, more than double the percentage rate increase of the S&P 500 index, on the back of a positive move by an analy
Announcement as on 13 March 2024

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 40.41
  • 12Day Average: 38.6
  • 20Day Average: 37.71
  • 50Day Average: 40.35
  • 100Day Average: 46.76
  • 150Day Average: 49.07
  • 200Day Average: 51.62

NVO Indicators & signals

Indicator MACD (12,26,9)

39.07, 38.99, -0.66
Indicator MACD is in positive zone

Indicator ADX (14)

16.67, 31.58, 22.56
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
20 Mon Apr 2026 40.47 39.75 to 40.85 -0.12% 0.63 times
17 Fri Apr 2026 40.52 40.43 to 41.29 -1% 1.04 times
16 Thu Apr 2026 40.93 40.23 to 41.66 0.29% 0.98 times
15 Wed Apr 2026 40.81 39.67 to 40.86 3.79% 1.52 times
14 Tue Apr 2026 39.32 37.91 to 39.78 3.53% 1.3 times
13 Mon Apr 2026 37.98 36.95 to 38.01 1.23% 1 times
10 Fri Apr 2026 37.52 37.23 to 38.42 0.19% 0.74 times
09 Thu Apr 2026 37.45 36.82 to 37.65 -0.43% 0.7 times
08 Wed Apr 2026 37.61 37.33 to 38.19 1.87% 1.09 times
07 Tue Apr 2026 36.92 35.97 to 37.25 0.71% 0.9 times
06 Mon Apr 2026 36.66 36.52 to 37.42 -0.87% 0.74 times
02 Thu Apr 2026 36.98 35.63 to 36.98 1.37% 0.9 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top